S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Avanir Pharmaceuticals Announces Initiation of Phase II Study of AVP-786 for the Adjunctive Treatment of Major Depressive Disorder|
|Avanir Pharmaceuticals Announces FDA Acceptance of IND for AVP-786 for the Adjunctive Treatment of Major Depressive Disorder|
|Concert Pharmaceuticals Achieves $2 Million Milestone for AVP-786 Under Avanir Pharmaceuticals Collaboration|
|Avcorp appoints new director|
|Avon Reports Second-Quarter 2014 Results|
|Avon Declares Regular Quarterly Dividend|
|Avanir Pharmaceuticals Announces Positive Phase II Trial Results for AVP-923 in Treatment of Agitation in Patients with Alzheimer's Disease|
|Allot Communications to Host Third Quarter 2014 Earnings Results Conference Call on Tuesday, November 4, 2014 (2014/10/6)|
|Avanir Pharmaceuticals Reports Fiscal 2014 Third Quarter Financial and Business Update|
|Avanir Pharmaceuticals Announces Data Presentations at the American Neurological Association's (ANA) 2014 Annual Meeting Including Results from the Phase II Trial for Treatment of Agitation in Patients with Alzheimer's Disease|
Click above to view more mutual fund data and stats for avpi - AVP Inc.